Nitecapone

Suppliers

Names

[ CAS No. ]:
116313-94-1

[ Name ]:
Nitecapone

[Synonym ]:
3-(3,4-dihydroxy-5-nitrobenzylidene)-2,4-pentanedione
2,4-Pentanedione,3-((3,4-dihydroxy-5-nitrophenyl)methylene)
Nitecapone
3-(3,4-dihydroxy-5-nitrophenyl)methylene-2,4-pentanedione
Nitecapona [INN-Spanish]
Nitecapone [INN]
OR 462
Nitecaponum [INN-Latin]

Chemical & Physical Properties

[ Density]:
1.451g/cm3

[ Boiling Point ]:
495.3ºC at 760 mmHg

[ Molecular Formula ]:
C12H11NO6

[ Molecular Weight ]:
265.21900

[ Flash Point ]:
211.6ºC

[ Exact Mass ]:
265.05900

[ PSA ]:
120.42000

[ LogP ]:
2.09060

[ Vapour Pressure ]:
1.95E-10mmHg at 25°C

[ Index of Refraction ]:
1.645

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
SA1942500
CHEMICAL NAME :
2,4-Pentanedione, 3-((3,4-dihydroxy-5-nitrophenyl)methylene)-
CAS REGISTRY NUMBER :
116313-94-1
LAST UPDATED :
199612
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C12-H11-N-O6
MOLECULAR WEIGHT :
265.24

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PHTOEH Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- Volume(issue)/page/year: 69,64,1991
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
507 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PHTOEH Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016 Copenhagen K, Denmark) V.60- 1987- Volume(issue)/page/year: 69,64,1991

Safety Information

[ Symbol ]:

GHS06

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H301

[ Precautionary Statements ]:
P301 + P310

[ RIDADR ]:
UN 2811 6.1 / PGIII

Synthetic Route

Precursor & DownStream

Precursor

  • 3,4-Dihydroxy-5-nitrobenzaldehyde
  • 2,4-Pentandione

DownStream

  • 3-(3-hydroxy-4-methoxy-5-nitrobenzylidene)-2,4-pentanedione

Articles

D1-like dopamine receptor activation and natriuresis by nitrocatechol COMT inhibitors.

Kidney Int. 59(5) , 1683-94, (2001)

In recent years, several nitrocatechol derivatives (tolcapone, entacapone, and nitecapone) have been developed and found to be highly selective and potent inhibitors of catechol-O-methyltransferase (C...

Extending levodopa action: COMT inhibition.

Neurology 50(6 Suppl 6) , S27-32; discussion S44-8, (1998)

Degradation of levodopa in the periphery is known to be associated with motor fluctuations and dyskinesia in Parkinson's disease (PD) patients. The enzyme catechol-O-methyltransferase (COMT) is respon...

The Helicobacter felis mouse model in assessing anti-Helicobacter therapies and gastric mucosal prostaglandin E2 levels.

Scand. J. Gastroenterol. 31(4) , 334-8, (1996)

The aims of the present study were to assess the usefulness of the Helicobacter felis mouse model in the evaluation of antimicrobial therapies and the effect of Helicobacter infection on gastric mucos...


More Articles


Related Compounds

  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 4,4,5,5-Tetramethyl-2-((1R,2S)-2-phenylcyclohexyl)-1,3,2-dioxaborolane
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • 1-(1,3-Benzodioxol-5-ylcarbonyl)-1,2,3,6-tetrahydro-pyridine
  • tert-Butyl-DL-alanine